{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-171014","form_type":"8-K","ticker":"AMLX","cik":"0001658551","company_name":"Amylyx Pharmaceuticals, Inc.","filed_at":"2022-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.679676+00:00","generated_at":"2026-06-25T03:11:50.018531+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Amylyx shareholders elect Class I directors and ratify Deloitte as auditor at 2022 annual meeting","bullets":["Justin Klee elected Class I director with 42,100,898 votes for, 1,607,476 withheld.","Isaac Cheng elected Class I director with 41,946,619 votes for, 1,761,755 withheld.","Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 43,834,729 votes for, 72,090 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-171014","json":"https://secwatch.observer/filing/0001193125-22-171014.json","markdown":"https://secwatch.observer/filing/0001193125-22-171014.md","text":"https://secwatch.observer/filing/0001193125-22-171014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658551/000119312522171014/0001193125-22-171014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658551/000119312522171014/d362452d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:11:50.018531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}